Pathology Grand Rounds: “Exponential Pathology: Triangulating Our AI-Enabled Future”

Ramy Arnaout, MD, DPhil, is a faculty member of the Division of Clinical Informatics and Associate Director of the Clinical Microbiology Laboratories. He is current President of the American Society of Microbiology, Northeast Branch and past Chairman of the FDA/CMS/CDC CLIA Committee. He received his SB from MIT, DPhil from Oxford University (Marshall Scholarship), and MD from Harvard Medical School (Soros Fellow). He completed a residency in pathology at Brigham and Women’s Hospital and postdoctoral work at the Broad Institute. His research laboratory uses computational biology, mathematics, physics, and engineering to understand complex biology, genomics, and medical systems, focusing on high-throughput immune repertoire genomic sequencing (computational systems immunology) and big data clinical data analytics. A past chairman of the Clinical Laboratory Improvement Act Committee, the federal standing committee that advises the FDA, CMS, and CDC on laboratory testing, his clinical practice includes directorship responsibilities in the clinical laboratories in the Department of Pathology. His work has been published in Nature, Nature Biotechnology, Proceedings of the National Academy of Sciences, and elsewhere. His work on research policy, genomics, clinical best practices, and utilization has been the subject of editorials and covered in the lay press.